J.-P. Pelletier

5.2k citations

63 papers · 4.2k indexed · 1 hit paper · h-index 27

Rheumatology top 0.1%
- Osteoarthritis Treatment and Mechanisms 46
- Rheumatoid Arthritis Research and Therapies 21
Equine top 1%
Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 20
Orthopedics and Sports Medicine top 2%
Cancer Research top 2%
- Protease and Inhibitor Mechanisms 4
Cell Biology
- Proteoglycans and glycosaminoglycans research 6
Genetics
- Chronic Lymphocytic Leukemia Research 4
Surgery
- Knee injuries and reconstruction techniques 4
Complementary and alternative medicine
- Medicinal plant effects and applications 3

Co-authors: Johanne Martel‐Pelletier Peter A. Revell Wim B. van den Berg Sergio A. Jiménez Donald M. Salter Kenneth P. H. Pritzker Steffen Gay Keld Østergaard
Cited by: Rheumatology Equine Pharmacology
Journals: Osteoarthritis and Cartilage (30 papers)Annals of the Rheumatic Diseases (8 papers)IEEE Transactions on Biomedical Engineering (1 paper)
Partner nations: Canada United States Australia

In The Last Decade

J.-P. Pelletier

58 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by J.-P. Pelletier

Since Specialization

Citations

This map shows the geographic impact of J.-P. Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Pelletier more than expected).

Fields of papers citing papers by J.-P. Pelletier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Pelletier. The network helps show where J.-P. Pelletier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J.-P. Pelletier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.-P. Pelletier Line = papers co-authored together J.-P. Pelletier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A multicentre randomised double-blind placebo-controlled trial of zoledronic acid for knee osteoarthritis - the zap2 trial Osteoarthritis and Cartilage ·Dawn Aitken,Guoqi Cai,Laura L Laslett,ShiWen Wang,Lyn March,Flavia Cicuttini,Anita E. Wluka,Yuanyuan Wang,Benny Antony,Leigh Blizzard,Tania Winzenberg,Johanne Martel‐Pelletier,J.-P. Pelletier,Graeme Jones	2020	2
2	Activation of the phosphatidylcholine to lysophosphatidylcholine pathway is associated with osteoarthritis knee cartilage volume loss over time: data from a 2-year multicentre clinical trial Osteoarthritis and Cartilage ·Guangju Zhai,J.-P. Pelletier,Ji Han Lee,Dawn Aitken,Edward Randell,Proton Rahman,Graeme Jones,Johanne Martel‐Pelletier	2019	1
3	Elevated serum biomarkers of inflammatory turnover of collagen types III and VI predict rapid cartilage loss Osteoarthritis and Cartilage ·Asger Reinstrup Bihlet,Marie-Thérèse Nugeyre,I. Byrjalsen,J.R. Andersen,Anne‐Christine Bay‐Jensen,J.-P. Pelletier,Johanne Martel‐Pelletier,M.A. Karsdal	2019	3
4	The ratio adipsin/MCP-1 is strongly associated with structural changes and CRP/MCP-1 with symptoms in obese knee osteoarthritis subjects: data from the Osteoarthritis Initiative Osteoarthritis and Cartilage ·Johanne Martel‐Pelletier,Ginette Tardif,Christiane Werner,F. Abram,Marc Dorais,J.-P. Raynauld,J.-P. Pelletier	2019	20
5	In a two-year double-blind randomized controlled multicenter study, chondroitin sulfate was significantly superior to celecoxib at reducing cartilage loss with similar efficacy at reducing disease symptoms in knee osteoarthritis patients Osteoarthritis and Cartilage ·J.-P. Pelletier,J.-P. Raynauld,A. D. Beaulieu,Louis Bessette,Frédéric Morin,洋二和田,F. Abram,Marc Dorais,Johanne Martel‐Pelletier	2016	3
6	Natural history and clinical significance of cartilage defects over 10 years in a mid-life cohort Osteoarthritis and Cartilage ·Li Yuanxi,Dawn Aitken,Changhai Ding,Leigh Blizzard,J.-P. Pelletier,Flavia Cicuttini,Graeme Jones	2015	1
7	Resveratrol Regulates the Wnt/ß-catenin pathway in human osteoarthritis osteoblasts Osteoarthritis and Cartilage ·Élie Abed,Aline Delalandre,J.-P. Pelletier,Johanne Martel‐Pelletier,Daniel Lajeunesse	2014	1
8	The long-term effects of SYSADOA treatment on knee osteoarthritis symptoms and progression of structural changes: participants from the Osteoarthritis Initiative progression cohort Osteoarthritis and Cartilage ·Johanne Martel‐Pelletier,C. Roubille,J.-P. Raynauld,F. Abram,Marc Dorais,Philippe Delorme,J.-P. Pelletier	2013	1
9	Expression of PPAR a, b, g, and H-and L-PGDS during osteoarthritis in the spontaneous Hartley guinea pig and the experimental dog models Osteoarthritis and Cartilage ·A. Campana,Osama Qutait,Hassan Afif,Mohit Kapoor,Mohamed Benderdour,J.-P. Pelletier,Johanne Martel‐Pelletier,Hassan Fahmi	2013	0
10	Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes Osteoarthritis and Cartilage ·N. Chabane,Nadia Zayed,Hassan Afif,Leandra Mfuna‐Endam,Mohamed Benderdour,S. D. Carpenter,Johanne Martel‐Pelletier,J.-P. Pelletier,N. Duval,Hassan Fahmi	2008	138
11	The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study Osteoarthritis and Cartilage ·Ginette Tardif,J.-P. Pelletier,Cathérine Boileau,Johanne Martel‐Pelletier	2008	34
12	Response to the Letter to the Editor by Roemer and collaborators entitled “MRI based semi-quantitative assessment of subchondral bone marrow lesions in osteoarthritis research” concerning the article published by d'Anjou et al. entitled “Temporal assessment of bone marrow lesions on magnetic resonance imaging in a canine model of knee osteoarthritis: impact of sequence selection.” Osteoarthritis and Cartilage ·Marc‐André d’Anjou,Éric Troncy,Maxim Moreau,F. Abram,J.-P. Raynauld,Johanne Martel‐Pelletier,J.-P. Pelletier	2008	4
13	Meniscal tear and increased tibial plateau bone area in healthy post-menopausal women Osteoarthritis and Cartilage ·Miranda Davies‐Tuck,J. Martel-Pelletier,Anita E. Wluka,J.-P. Pelletier,Changhai Ding,Graeme Jones,Susan R. Davis,Flavia Cicuttini	2008	17
14	Temporal assessment of bone marrow lesions on magnetic resonance imaging in a canine model of knee osteoarthritis: impact of sequence selection Osteoarthritis and Cartilage ·Marc‐André d’Anjou,Éric Troncy,Maxim Moreau,F. Abram,J.-P. Raynauld,Johanne Martel‐Pelletier,J.-P. Pelletier	2008	26
15	Osteoarthritis cartilage histopathology: grading and stagingbreakdown → Osteoarthritis and Cartilage ·Kenneth P. H. Pritzker,Steffen Gay,Sergio A. Jiménez,Keld Østergaard,J.-P. Pelletier,Peter A. Revell,Donald M. Salter,Wim B. van den Berg	2005	1861
16	Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation and transcription initiation sites Osteoarthritis and Cartilage ·Ginette Tardif,Martine Dupuis,Pascal Reboul,Changshan Geng,J.-P. Pelletier,Pierre Ranger,Johanne Martel‐Pelletier	2003	10
17	Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander Modern Rheumatology ·Daniel Lajeunesse,Frédéric Massicotte,J.-P. Pelletier,T Kubo	2003	36
18	15d-PGJ2 is acting as a ‘dual agent’ on the regulation of COX-2 expression in human osteoarthritic chondrocytes Osteoarthritis and Cartilage ·Hassan Fahmi,J.-P. Pelletier,François Mineau,Johanne Martel‐Pelletier	2002	48
19	The influence of tissue cross-talking on OA progression: role of nonsteroidal antiinflammatory drugs Osteoarthritis and Cartilage ·J.-P. Pelletier	1999	31
20	Rôle de l'inflammation synoviale, des cytokines et de l'IGF-1 dans la physiopathologie de l'arthrose Revue du Rhumatisme ·J.-P. Pelletier,Johanne Martel‐Pelletier	1994	1

About J.-P. Pelletier

J.-P. Pelletier is a scholar working on Rheumatology, Pharmacology, Equine, Cancer Research and Genetics, having authored 63 papers that have together received 4.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (46 papers), Rheumatoid Arthritis Research and Therapies (21 papers), Inflammatory mediators and NSAID effects (20 papers), Proteoglycans and glycosaminoglycans research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Knee injuries and reconstruction techniques (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Medicinal plant effects and applications (3 papers). The work is most often cited by research in Rheumatology (3.1k citations), Equine (157 citations), Pharmacology (1.0k citations), Orthopedics and Sports Medicine (453 citations) and Cancer Research (763 citations). J.-P. Pelletier has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Johanne Martel‐Pelletier, Peter A. Revell, Wim B. van den Berg, Sergio A. Jiménez, Donald M. Salter, Kenneth P. H. Pritzker, Steffen Gay, Keld Østergaard, J M Cloutier and Ginette Tardif. Their work appears in journals such as Osteoarthritis and Cartilage, Annals of the Rheumatic Diseases, IEEE Transactions on Biomedical Engineering, Modern Rheumatology and Inflammopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact